Veterans with ALS Reporting Act
Summary
What This Bill Does
Requires VA, in consultation with CDC, to report on ALS incidence and prevalence among veterans, track prevalence using the CDC registry and biorepository, and provide recurring updates.
Who Benefits and How
Veterans with ALS and policymakers could gain better information on disease prevalence, support gaps, risk-reduction strategies, and research participation pathways.
Who Bears the Burden and How
VA and CDC would have to compile the initial report, track prevalence, and provide recurring updates to Congress.
Key Provisions
- Requires an initial report on ALS incidence and prevalence in veterans within one year.
- Requires assessment of support, deficiencies, risk-reduction strategies, clinical-trial pathways, and legislative recommendations.
- Requires VA to track veteran ALS prevalence using the CDC ALS registry and biorepository and provide updates every three years.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires VA, in consultation with CDC, to report on ALS incidence and prevalence among veterans, track prevalence using the CDC registry and biorepository, and provide recurring updates.
Key Policy Areas
Veterans Affairs, Healthcare, Government Operations
Primary Purpose
Requires VA, in consultation with CDC, to report on ALS incidence and prevalence among veterans, track prevalence using the CDC registry and biorepository, and provide recurring updates.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Veterans with ALS and policymakers seeking better data and support strategies
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- VA and CDC officials responsible for reporting, tracking prevalence, and recurring updates
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeSubcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Subcommittee Hearings Held
Referred to the Subcommittee on Health.
Referred to the House Committee on Veterans' Affairs.
Mr. Crow (for himself, Mr. Calvert, Ms. Sewell, and Mr. …
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Veterans with ALS who could benefit from better federal tracking, support assessment, and research pathways
VA and CDC officials responsible for reporting, prevalence tracking, and recurring updates
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_director"
- → Director of the Centers for Disease Control and Prevention
- "the_secretary"
- → Secretary of Veterans Affairs
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology